These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 30031971)
1. Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities. Knez D; Coquelle N; Pišlar A; Žakelj S; Jukič M; Sova M; Mravljak J; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S Eur J Med Chem; 2018 Aug; 156():598-617. PubMed ID: 30031971 [TBL] [Abstract][Full Text] [Related]
2. Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer's Disease. Knez D; Sosič I; Pišlar A; Mitrović A; Jukič M; Kos J; Gobec S Curr Alzheimer Res; 2019; 16(9):801-814. PubMed ID: 31660830 [TBL] [Abstract][Full Text] [Related]
3. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease. Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780 [TBL] [Abstract][Full Text] [Related]
4. Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer's disease. Mi J; He Y; Yang J; Zhou Y; Zhu G; Wu A; Liu W; Sang Z Bioorg Med Chem Lett; 2022 Mar; 60():128574. PubMed ID: 35065231 [TBL] [Abstract][Full Text] [Related]
5. Novel salicylamide derivatives as potent multifunctional agents for the treatment of Alzheimer's disease: Design, synthesis and biological evaluation. Song Q; Li Y; Cao Z; Qiang X; Tan Z; Deng Y Bioorg Chem; 2019 Mar; 84():137-149. PubMed ID: 30500523 [TBL] [Abstract][Full Text] [Related]
6. Search for new multi-target compounds against Alzheimer's disease among histamine H Bajda M; Łażewska D; Godyń J; Zaręba P; Kuder K; Hagenow S; Łątka K; Stawarska E; Stark H; Kieć-Kononowicz K; Malawska B Eur J Med Chem; 2020 Jan; 185():111785. PubMed ID: 31669851 [TBL] [Abstract][Full Text] [Related]
7. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease. Wichur T; Więckowska A; Więckowski K; Godyń J; Jończyk J; Valdivieso ÁDR; Panek D; Pasieka A; Sabaté R; Knez D; Gobec S; Malawska B Eur J Med Chem; 2020 Feb; 187():111916. PubMed ID: 31812794 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer's disease. Wang K; Shi J; Zhou Y; He Y; Mi J; Yang J; Liu S; Tang X; Liu W; Tan Z; Sang Z Bioorg Chem; 2021 Jul; 112():104879. PubMed ID: 33915461 [TBL] [Abstract][Full Text] [Related]
9. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents. Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361 [TBL] [Abstract][Full Text] [Related]
10. Development of cyanopyridine-triazine hybrids as lead multitarget anti-Alzheimer agents. Maqbool M; Manral A; Jameel E; Kumar J; Saini V; Shandilya A; Tiwari M; Hoda N; Jayaram B Bioorg Med Chem; 2016 Jun; 24(12):2777-88. PubMed ID: 27157006 [TBL] [Abstract][Full Text] [Related]
11. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease. Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease. Liu T; Chen S; Du J; Xing S; Li R; Li Z Eur J Med Chem; 2022 Jan; 227():113973. PubMed ID: 34752955 [TBL] [Abstract][Full Text] [Related]
13. N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents. Košak U; Knez D; Coquelle N; Brus B; Pišlar A; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S Bioorg Med Chem; 2017 Jan; 25(2):633-645. PubMed ID: 27908752 [TBL] [Abstract][Full Text] [Related]
14. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities. Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969 [TBL] [Abstract][Full Text] [Related]
15. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease. Sang Z; Wang K; Shi J; Liu W; Cheng X; Zhu G; Wang Y; Zhao Y; Qiao Z; Wu A; Tan Z Eur J Med Chem; 2020 Apr; 192():112180. PubMed ID: 32131034 [TBL] [Abstract][Full Text] [Related]
16. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease. Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079 [TBL] [Abstract][Full Text] [Related]
17. Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease. Sang Z; Wang K; Shi J; Cheng X; Zhu G; Wei R; Ma Q; Yu L; Zhao Y; Tan Z; Liu W Eur J Med Chem; 2020 Feb; 187():111958. PubMed ID: 31865014 [TBL] [Abstract][Full Text] [Related]
19. Development of genistein-O-alkylamines derivatives as multifunctional agents for the treatment of Alzheimer's disease. Sang Z; Shi J; Zhou Y; Wang K; Zhao Y; Li Q; Qiao Z; Wu A; Tan Z; Liu W Bioorg Chem; 2021 Feb; 107():104602. PubMed ID: 33453647 [TBL] [Abstract][Full Text] [Related]
20. Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse Model. Scheiner M; Hoffmann M; He F; Poeta E; Chatonnet A; Monti B; Maurice T; Decker M J Med Chem; 2021 Jul; 64(13):9302-9320. PubMed ID: 34152756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]